Effect of the “universal test and treat” policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda

We examined the effect of the Universal Test and Treat (UTT) policy on the characteristics of people living with HIV (PLHIV) at enrolment in HIV care and initiation of antiretroviral therapy (ART) in Uganda using data from 11 nationally representative clinics of The AIDS Support Organisation (TASO)....

Full description

Bibliographic Details
Main Authors: Levicatus Mugenyi, Christian H. Hansen, Philippe Mayaud, Janet Seeley, Robert Newton, Mastula Nanfuka, Andrew Abaasa, Kenneth Mugisha, Michael Etukoit, Pontiano Kaleebu, Eugene Ruzagira
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2023.1187274/full
_version_ 1797808464419880960
author Levicatus Mugenyi
Christian H. Hansen
Christian H. Hansen
Philippe Mayaud
Philippe Mayaud
Janet Seeley
Janet Seeley
Robert Newton
Mastula Nanfuka
Andrew Abaasa
Kenneth Mugisha
Michael Etukoit
Pontiano Kaleebu
Pontiano Kaleebu
Eugene Ruzagira
Eugene Ruzagira
author_facet Levicatus Mugenyi
Christian H. Hansen
Christian H. Hansen
Philippe Mayaud
Philippe Mayaud
Janet Seeley
Janet Seeley
Robert Newton
Mastula Nanfuka
Andrew Abaasa
Kenneth Mugisha
Michael Etukoit
Pontiano Kaleebu
Pontiano Kaleebu
Eugene Ruzagira
Eugene Ruzagira
author_sort Levicatus Mugenyi
collection DOAJ
description We examined the effect of the Universal Test and Treat (UTT) policy on the characteristics of people living with HIV (PLHIV) at enrolment in HIV care and initiation of antiretroviral therapy (ART) in Uganda using data from 11 nationally representative clinics of The AIDS Support Organisation (TASO). We created two retrospective PLHIV cohorts: pre-UTT (2004–2016), where ART initiation was conditional on CD4 cell count and UTT (2017–2022), where ART was initiated regardless of World Health Organisation (WHO) clinical stage or CD4 cell count. We used a two-sample test of proportions and Wilcoxon rank-sum test to compare proportions and medians, respectively, between the cohorts. A total of 244,693 PLHIV were enrolled at the clinics [pre-UTT, 210,251 (85.9%); UTT, 34,442 (14.1%)]. Compared to the pre-UTT cohort, the UTT cohort had higher proportions of PLHIV that were male (p < 0.001), aged 18–29 years (p < 0.001), aged >69 years, never married (p < 0.001), and educated to primary (p < 0.001) and post-primary (p < 0.001) school level at enrolment in HIV care and ART initiation. Overall, 97.9% of UTT PLHIV initiated ART compared to 45.2% under pre-UTT. The median time from enrolment in HIV care to ART initiation decreased from 301 [interquartile range (IQR): 58–878] pre-UTT to 0 (IQR: 0–0) under UTT. The median CD4 count at ART initiation increased from 254 cells/μL pre-UTT to 482 cells/μL under UTT (p < 0.001). Compared to the pre-UTT cohort, the UTT cohort had higher proportions of PLHIV with a CD4 count >500 cells/μL (47.3% vs. 13.2%, p < 0.001) and WHO stage 1 (31.7% vs. 4.5%, p < 0.001) at ART initiation. Adoption of the UTT policy in Uganda was successful in enrolling previously unreached individuals, such as men and younger and older adults, as well as those with less advanced HIV disease. Future research will investigate the effect of UTT on long-term outcomes such as retention in care, HIV viral suppression, morbidity, and mortality.
first_indexed 2024-03-13T06:37:53Z
format Article
id doaj.art-37e8ac7d61b44351b0ebaf7c9257361e
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-03-13T06:37:53Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-37e8ac7d61b44351b0ebaf7c9257361e2023-06-09T04:21:41ZengFrontiers Media S.A.Frontiers in Public Health2296-25652023-06-011110.3389/fpubh.2023.11872741187274Effect of the “universal test and treat” policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in UgandaLevicatus Mugenyi0Christian H. Hansen1Christian H. Hansen2Philippe Mayaud3Philippe Mayaud4Janet Seeley5Janet Seeley6Robert Newton7Mastula Nanfuka8Andrew Abaasa9Kenneth Mugisha10Michael Etukoit11Pontiano Kaleebu12Pontiano Kaleebu13Eugene Ruzagira14Eugene Ruzagira15MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, UgandaMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, UgandaLondon School of Hygiene & Tropical Medicine, London, United KingdomMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, UgandaLondon School of Hygiene & Tropical Medicine, London, United KingdomMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, UgandaLondon School of Hygiene & Tropical Medicine, London, United KingdomMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, UgandaThe AIDS Support Organization, Kampala, UgandaMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, UgandaThe AIDS Support Organization, Kampala, UgandaThe AIDS Support Organization, Kampala, UgandaMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, UgandaLondon School of Hygiene & Tropical Medicine, London, United KingdomMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, UgandaLondon School of Hygiene & Tropical Medicine, London, United KingdomWe examined the effect of the Universal Test and Treat (UTT) policy on the characteristics of people living with HIV (PLHIV) at enrolment in HIV care and initiation of antiretroviral therapy (ART) in Uganda using data from 11 nationally representative clinics of The AIDS Support Organisation (TASO). We created two retrospective PLHIV cohorts: pre-UTT (2004–2016), where ART initiation was conditional on CD4 cell count and UTT (2017–2022), where ART was initiated regardless of World Health Organisation (WHO) clinical stage or CD4 cell count. We used a two-sample test of proportions and Wilcoxon rank-sum test to compare proportions and medians, respectively, between the cohorts. A total of 244,693 PLHIV were enrolled at the clinics [pre-UTT, 210,251 (85.9%); UTT, 34,442 (14.1%)]. Compared to the pre-UTT cohort, the UTT cohort had higher proportions of PLHIV that were male (p < 0.001), aged 18–29 years (p < 0.001), aged >69 years, never married (p < 0.001), and educated to primary (p < 0.001) and post-primary (p < 0.001) school level at enrolment in HIV care and ART initiation. Overall, 97.9% of UTT PLHIV initiated ART compared to 45.2% under pre-UTT. The median time from enrolment in HIV care to ART initiation decreased from 301 [interquartile range (IQR): 58–878] pre-UTT to 0 (IQR: 0–0) under UTT. The median CD4 count at ART initiation increased from 254 cells/μL pre-UTT to 482 cells/μL under UTT (p < 0.001). Compared to the pre-UTT cohort, the UTT cohort had higher proportions of PLHIV with a CD4 count >500 cells/μL (47.3% vs. 13.2%, p < 0.001) and WHO stage 1 (31.7% vs. 4.5%, p < 0.001) at ART initiation. Adoption of the UTT policy in Uganda was successful in enrolling previously unreached individuals, such as men and younger and older adults, as well as those with less advanced HIV disease. Future research will investigate the effect of UTT on long-term outcomes such as retention in care, HIV viral suppression, morbidity, and mortality.https://www.frontiersin.org/articles/10.3389/fpubh.2023.1187274/fulluniversal test and treatHIV/AIDSantiretroviral therapyTASOUganda
spellingShingle Levicatus Mugenyi
Christian H. Hansen
Christian H. Hansen
Philippe Mayaud
Philippe Mayaud
Janet Seeley
Janet Seeley
Robert Newton
Mastula Nanfuka
Andrew Abaasa
Kenneth Mugisha
Michael Etukoit
Pontiano Kaleebu
Pontiano Kaleebu
Eugene Ruzagira
Eugene Ruzagira
Effect of the “universal test and treat” policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda
Frontiers in Public Health
universal test and treat
HIV/AIDS
antiretroviral therapy
TASO
Uganda
title Effect of the “universal test and treat” policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda
title_full Effect of the “universal test and treat” policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda
title_fullStr Effect of the “universal test and treat” policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda
title_full_unstemmed Effect of the “universal test and treat” policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda
title_short Effect of the “universal test and treat” policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda
title_sort effect of the universal test and treat policy on the characteristics of persons registering for hiv care and initiating antiretroviral therapy in uganda
topic universal test and treat
HIV/AIDS
antiretroviral therapy
TASO
Uganda
url https://www.frontiersin.org/articles/10.3389/fpubh.2023.1187274/full
work_keys_str_mv AT levicatusmugenyi effectoftheuniversaltestandtreatpolicyonthecharacteristicsofpersonsregisteringforhivcareandinitiatingantiretroviraltherapyinuganda
AT christianhhansen effectoftheuniversaltestandtreatpolicyonthecharacteristicsofpersonsregisteringforhivcareandinitiatingantiretroviraltherapyinuganda
AT christianhhansen effectoftheuniversaltestandtreatpolicyonthecharacteristicsofpersonsregisteringforhivcareandinitiatingantiretroviraltherapyinuganda
AT philippemayaud effectoftheuniversaltestandtreatpolicyonthecharacteristicsofpersonsregisteringforhivcareandinitiatingantiretroviraltherapyinuganda
AT philippemayaud effectoftheuniversaltestandtreatpolicyonthecharacteristicsofpersonsregisteringforhivcareandinitiatingantiretroviraltherapyinuganda
AT janetseeley effectoftheuniversaltestandtreatpolicyonthecharacteristicsofpersonsregisteringforhivcareandinitiatingantiretroviraltherapyinuganda
AT janetseeley effectoftheuniversaltestandtreatpolicyonthecharacteristicsofpersonsregisteringforhivcareandinitiatingantiretroviraltherapyinuganda
AT robertnewton effectoftheuniversaltestandtreatpolicyonthecharacteristicsofpersonsregisteringforhivcareandinitiatingantiretroviraltherapyinuganda
AT mastulananfuka effectoftheuniversaltestandtreatpolicyonthecharacteristicsofpersonsregisteringforhivcareandinitiatingantiretroviraltherapyinuganda
AT andrewabaasa effectoftheuniversaltestandtreatpolicyonthecharacteristicsofpersonsregisteringforhivcareandinitiatingantiretroviraltherapyinuganda
AT kennethmugisha effectoftheuniversaltestandtreatpolicyonthecharacteristicsofpersonsregisteringforhivcareandinitiatingantiretroviraltherapyinuganda
AT michaeletukoit effectoftheuniversaltestandtreatpolicyonthecharacteristicsofpersonsregisteringforhivcareandinitiatingantiretroviraltherapyinuganda
AT pontianokaleebu effectoftheuniversaltestandtreatpolicyonthecharacteristicsofpersonsregisteringforhivcareandinitiatingantiretroviraltherapyinuganda
AT pontianokaleebu effectoftheuniversaltestandtreatpolicyonthecharacteristicsofpersonsregisteringforhivcareandinitiatingantiretroviraltherapyinuganda
AT eugeneruzagira effectoftheuniversaltestandtreatpolicyonthecharacteristicsofpersonsregisteringforhivcareandinitiatingantiretroviraltherapyinuganda
AT eugeneruzagira effectoftheuniversaltestandtreatpolicyonthecharacteristicsofpersonsregisteringforhivcareandinitiatingantiretroviraltherapyinuganda